Citation Impact
78 standout
Citing Papers
Drug repurposing for cancer therapy
2024 Standout
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
2024 Standout
Works of R. Dunn being referenced
Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol
2021
EMD121974 (NSC 707544, cilengitide) in asymptomatic metastatic androgen independent prostate cancer (AIPCa) patients (pts): A randomized trial by the Prostate Cancer Clinical Trials Consortium (NCI 6372)
2007
Author Peers
| Author | Oncology | Reproductive Medicine | PRM | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| R. Dunn | 23 | 18 | 4 | 10 | 5 | 32 | |
| P. L. Lantos | 44 | 13 | 533 | 29 | 1.4k | ||
| Ming‐Der Kuo | 40 | 4 | 36 | 127 | 12 | 471 | |
| R. I. Bradley | 7 | 16 | 1.6k | ||||
| Christopher Hall | 33 | 12 | 49 | 244 | 25 | 499 | |
| Keiichi Hirano | 12 | 8 | 295 | 54 | 2.3k |
All Works
Loading papers...